Dare Bioscience Correlations

DARE Stock  USD 1.92  0.05  2.54%   
The current 90-days correlation between Dare Bioscience and FibroBiologics Common Stock is -0.23 (i.e., Very good diversification). The correlation of Dare Bioscience is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Dare Bioscience Correlation With Market

Very weak diversification

The correlation between Dare Bioscience and DJI is 0.41 (i.e., Very weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Dare Bioscience and DJI in the same portfolio, assuming nothing else is changed.
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Dare Bioscience. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
For information on how to trade Dare Stock refer to our How to Trade Dare Stock guide.

Moving against Dare Stock

  0.37GLABF Gemina LaboratoriesPairCorr
  0.45T ATT Inc Earnings Call This WeekPairCorr

Related Correlations Analysis


Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

HOTHAIMD
HOTHCTXR
ASBPAIMD
AIMDCTXR
HOTHASBP
ADTXAIMD
  

High negative correlations

ATHACTXR
HOTHLPTX
HOTHATHA
ASBPATHA
ATHAAIMD
LPTXCTXR

Risk-Adjusted Indicators

There is a big difference between Dare Stock performing well and Dare Bioscience Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Dare Bioscience's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
FBLG  5.99  0.15  0.01  0.20  8.28 
 14.71 
 47.13 
CTXR  4.70 (1.12) 0.00 (0.47) 0.00 
 10.59 
 38.23 
LPTX  14.85  6.65  0.64 (8.07) 6.90 
 25.00 
 65.13 
AIMD  3.95 (0.83) 0.00 (0.21) 0.00 
 11.43 
 28.00 
ATHA  4.22  0.85  0.25  0.32  3.40 
 7.83 
 70.38 
ASBP  7.94 (2.50) 0.00  5.79  0.00 
 19.52 
 63.79 
ADTX  11.40 (4.15) 0.00 (16.16) 0.00 
 22.54 
 63.67 
PALI  6.09  0.23  0.02 (0.19) 6.58 
 13.86 
 31.35 
ANL  5.95  1.43  0.20  11.08  5.83 
 15.22 
 42.22 
HOTH  2.50 (0.60) 0.00 (0.26) 0.00 
 4.81 
 14.85 

Dare Bioscience Corporate Management

David FriendChief OfficerProfile
MarDee HaringLaytonChief OfficerProfile
John FairChief Business OfficerProfile
Lisa WaltersHoffertExecutive OfficerProfile
Jennifer KiangVice DevelopmentProfile
Mark WaltersVice OperationsProfile